A firm randomly assigned its scientists AI: here’s what happened

Scientists at an unnamed corporate laboratory were randomly assigned a machine-learning tool.Credit: Eugenio Marongiu/GettyArtificial intelligence (AI) is becoming ubiquitous in applied research, but can it actually invent useful materials faster than humans can? It is still too early to tell, but a massive study suggests that it might.Researchers built an ‘AI Scientist’ — what can it do?Aidan Toner-Rodgers, an economist at the Massachusetts Institute of Technology (MIT) in Cambridge, followed the deployment of a machine-learning tool at an unnamed corporate laboratory employing more than 1,000 researchers. Teams that were randomly assigned to use the tool discovered 44% more new materials and filed 39% more patent applications than did the ones that stuck to their standard workflow, he found. Toner-Rodgers posted the results online last month, and has submitted them to a peer-reviewed journal.“It is a very interesting paper,” says Robert Palgrave, a solid-state chemist at University College London, adding that the limited disclosure of the trial’s details makes the results of the AI deployment hard to evaluate. “It maybe doesn’t surprise me that AI can come up with a lot of suggestions,” Palgrave says. “What we’re kind of missing is whether those suggestions were good suggestions or not.”Materials makerToner-Rodgers had access to internal data from the lab and interviewed the researchers under the condition that he would not disclose the name of the company or the specific products it designed. He writes that it is a US firm that develops new inorganic materials — including molecular compounds, crystal structures, glasses and metal alloys — for use in “healthcare, optics, and industrial manufacturing”.Do AI models produce more original ideas than researchers?Starting in 2022, the company systematically adopted an AI tool that it had customized to fit its needs. According to Toner-Rodgers, the tool combines graph neural networks — a popular approach in materials discovery that has been used by DeepMind, Google’s London-based AI firm, among others — with reinforcement learning. The neural network was pre-trained using data from vast existing databases, including crystal structures and their properties from the Materials Project and molecular structures from the Alexandria Materials Database.Researchers input requirements for a material’s desired properties into the neural network, and the system suggests structures for new materials that could have those properties. The teams then weed out potential duds — such as formulas that would not lead to a stable compound — using their own specialist knowledge and computer simulations. They then attempt to synthesize the candidate structures and, if successful, test them in experiments and even in prototypes of finished products. The results are fed back into the neural network — the ‘reinforcement’ stage that helps it to improve its predictive abilities.Mixed resultsOverall, the teams that used the AI tools designed more new materials than did the ones following the standard workflow. But Toner-Rodgers also found unevenness among the AI-powered teams. Researchers who had been ranked as the company’s top performers got even better, whereas the bottom ones did not seem to get much benefit. “Top scientists leverage their domain knowledge to prioritize promising AI suggestions, while others waste significant resources testing false positives,” he writes.Could AI help you to write your next paper?“The finding that high-performing researchers get the most out of AI, to me, is the most interesting result, regardless of whether this is just perception or reality,” says Jevin West, a computational social scientist at the University of Washington in Seattle.It usually takes years, or even decades, for a new material to be developed and incorporated into a product and enter mass production, so a two-year study cannot measure the ultimate success of the inventions. Instead, Toner-Rodgers used various objective metrics, such as the occurrences of certain pairs of words in the text of patent applications, to find that the AI-designed materials were ‘more novel’ — meaning farther away from the ones in the original databases — than the human-designed ones. This was the most surprising finding, he says, showing that the AI tool did not simply regurgitate knowledge.But existing metrics, such as those used by Toner-Rodgers, have limitations, West says, and the company’s secrecy “really limits the potential engagement of this study by other researchers”. Palgrave agrees, saying that the lack of any details about how exactly these materials perform better than others makes it difficult to evaluate even the initial results. Still, he adds, “it seems like their teams would not bother filing patents and making prototypes unless they thought so — but we don’t have that direct evidence”. And both West and Palgrave commend the company for having set up a randomized study in early 2022, before the release of the AI-powered chatbot ChatGPT caused an explosion in interest in machine learning.In a follow-up questionnaire, the researchers using AI-powered workflows reported less satisfaction with their jobs: the tool had taken away some of the more creative steps in their work, and left the scientists mostly to select which suggested materials to take to the next stage. “Evaluating AI suggestions is important, but it’s less enjoyable,” says Toner-Rodgers.

Former NHS Chief Exec to lead behavioural science and conservational AI initiative to ‘transform’ health and care

Former NHS England Director and NHS Chief Executive, Richard Samuel, has joined EBO, a conversational AI vendor, as Director of Healthcare Strategy. He will lead a transformative initiative aimed at revolutionising the role of the patient in the reform of the NHS.

“Placing the person at the heart of the service and in control of their care is essential,” says Richard.

The potential for health and care sector to harness AI and behavioural science to creating proactive, personalised, and scalable ‘robot’ conversations is enormous and a step we must take to elevate patient care and people’s experience to new standards of excellence.

This initiative aligns with the NHS Long Term Plan’s focus on prevention, early intervention, and patient empowerment. AI-based tools, like vaccination chatbots are already demonstrating huge success: Shropshire has reported a 40% increase in vaccination rates, and early data from NELFT suggests that DNAs can be reduced by as much as 20% driven by timely AI nudges and behavioural science principles.

Richard said: “I am raring to go with this initiative: to build a portfolio of autonomous ‘patient healthcare navigators’. A critical success factor will be the support coming from within industry. We want to work with existing clinical suppliers in defining objectives and identifying behavioural barriers to piloting, evaluating, and refining conversational AI interventions”.

EBO’s CEO, Gege Gatt commented: “Richard Samuel brings a unique blend of NHS experience and AI expertise, making him ideally suited to spearhead this ambitious program. His vision is to incorporate behavioural insights within AI-powered systems to transform NHS care delivery. We look forward to seeing Richard’s leadership and the meaningful outcomes that will emerge from this groundbreaking program.

DelVal Poultry Science Center gets $2 million boost

Delaware Valley University (DelVal) has received a $2,025,000 Redevelopment Assistance Capital Program (RACP) grant from the Pennsylvania Department of Budget to support the construction of a new Poultry Science Center on the main campus in Doylestown, Pennsylvania. Gov. Josh Shapiro’s office announced the grant awards on November 2. The university first announced plans for the new facility in July 2023.“We are thrilled to receive this vital funding that accelerates our ability to build a state-of-the-art facility dedicated to advancing poultry research, education and innovation,” said DelVal President Dr. Benjamin Rusiloski. “This grant, along with the cornerstone gift from Mountaire Farms, Inc., puts us significantly closer to breaking ground for the new facility. The need for research, innovation and teaching in poultry science is critical to support the ongoing growth in the poultry industry in the United States and worldwide.”The new Poultry Science Center will provide modern research laboratories, classrooms, and demonstration spaces designed to foster collaboration between students, faculty and industry experts. The facility will also have the capacity to produce 5,000 birds every 6 to 8 weeks, providing an additional revenue stream to support teaching and learning at DelVal.“We extend our thanks to Sen. (Steve) Santarsiero and Rep. (Tim) Brennan for their assistance in securing this grant,” added Dr. Rusiloski.“Delaware Valley University, as a leader in agricultural science education, is uniquely positioned to meet the growing need for higher education programs focused on poultry science,” Santarsiero said. “The new Poultry Science Center will provide students with hands-on educational experience to successfully join this growing work force while providing continuing education to local processors and industry professionals.”Brennan added: “In my first term, I worked to preserve agriculture space, advancing a bill to save more farms – a huge challenge in the 21st century.  Projects like this make sure we are doing the most we can with that preserved space.  Delaware Valley University (DelVal) has consistently demonstrated a commitment to excellence in agricultural sciences, and the Poultry Science Center is a testament to the institution’s dedication to innovation and progress. This project is important to Bucks County, not only in terms of education and research, but also in promoting economic growth and sustainability.”

ARTx3 presents holiday variety show ‘Miracle on Main’ Dec. 20-21 at Arts & Science Center

Cast members of “Miracle on Main: A Holiday Special” rehearse a number in the Catherine M. Bellamy Theater at The Arts & Science Center for Southeast Arkansas in Pine Bluff. Performances of the holiday variety show are 7 p.m. Friday, Dec. 20 and Saturday, Dec. 21.PINE BLUFF, Ark. —  The ARTx3 Campus and its volunteer performers are bringing holiday music, stories, and more to the stage with “Miracle on Main: A Holiday Special.” Performances are at 7 p.m. Friday, Dec. 20, and Saturday, Dec. 21, in the Catherine M. Bellamy Theater at The Arts & Science Center for Southeast Arkansas (ASC), 701 S. Main St.Inspired by holiday variety shows on television, “Miracle on Main” features singing, dancing, comedy skits, and more. The show, first presented in 2022, is also an opportunity to showcase the talent of local performers outside of the scripted and heavily rehearsed plays and musicals.Bethany Gere and Kayla Earnest direct this year’s show. Gere’s directing credits include this summer’s production of “Roald Dahl’s Matilda The Musical,” and Earnest with this spring’s staging of “The Secret Garden.”“‘Miracle on Main’ is a community talent show and this is the second time we have been able to put together a show like this for our organization,” Gere said. “We really wanted to give a chance for people to be able to perform who can’t commit to a full rehearsal schedule. Plus, who doesn’t love a heartwarming holiday show to kick off such a special time of year for so many people?”The performers range in age from 6 to adult, with a mix of newcomers and theater veterans.“With this show, we have so many new performers,” Gere said. “I don’t want to give too much away but we will have everything you can think of, from instrumentalists to ventriloquists. This is also a special type of show because we are able to lower our age limit to 6 years old to give our littlest performers their first taste of the spotlight.”In addition to Earnest and Gere, the cast includes Lajoiy Ajayi, Addie Ashcraft, Isaiah Austin, Patchez Black, Emily Burris, Allison Carraway, Lindsey Collins, Langston Cosner, Laura Cosner, T’waun Dockett, Rory Earnest-Lake, Kamiah Fair, Geoffrey Gallinero, Melody Gere, Kaleb Hughes, Ivy Joyner, Brandt Lunsford, Bree Lunsford, Brooks Lunsford, Heather Lunsford, Avery Martin, Caleb Menard, Violet Myers, Terrance Ricks, Amber Robinson, Kasey Rowland, Greg Simmons, JC Spinks, Sawyer Terry, Hazel Thompson, Madelyn Thompson, Oliva Thompson, Whitney Tippy, Teanna Williams, Andrea Woodfield and Maleah Woods.This year’s “Miracle on Main” features two new large-group performances. One is a reader’s theater piece to “Olive, The Other Reindeer,” in which performers act out the beloved storybook by Vivian Walsh and J. Otto Seibold. The other big piece in the show is a community choir. “This has been a passion project for me,” Gere said. “I chose the song ‘Christmas Wish’ because of what it stands for. We all need more love and unity in our lives and I thought this was the perfect song to embody that. We have so many talented performers that we can’t wait for you to see.”The public can get a sampling of “Miracle on Main” when cast members perform in the City of Pine Bluff’s Christmas parade on Tuesday, Dec. 3. The event kicks off at 5:30 p.m. on Main Street.“Miracle on Main” is the final show of the ARTx3 Campus’ theater season. This year, the campus celebrated the 30th anniversary of the 242-seat Catherine M. Bellamy Theater.Tickets are $20 each. To purchase, visit artx3.org/all-events/miracle-on-main or call 870- 536-3375. Tickets may also be purchased in person at ASC during business hours and before each performance.For more information about “Miracle on Main,” contact Interim Director Lindsey Collins at [email protected] or call 870-536-3375.

Scientists reveal ‘neural tourniquet’ that can stop bleeding with nerve stimulation

Zapping the vagus nerve promotes blood clotting, new research suggests.These findings are the first evidence in humans of a “neural tourniquet,” or a brain-based pathway that could reduce bleeding, said study co-author Dr. Jared Huston, a trauma surgeon at the Firestein Institutes for Medical Research at Northwell Health in New York.If a future clinical trial directly shows that the nerve stimulation decreases blood loss, the technique could be used before planned surgeries to protect patients from excessive bleeding, Huston told Live Science.Around 1.5% of surgeries are complicated by haemorrhaging, or excessive blood loss, and some degree of bleeding is associated with all surgeries. Surgeons currently rely on sutures, bandages and tourniquets — devices that stop blood from flowing to part of the body — to staunch bleeding.But Huston wondered whether making blood less likely to escape in the first place would make surgery safer. “Preventing a problem is always better than dealing with it after the fact,” he said.Related: How much blood is in the human body?Huston and his collaborators first wondered if the vagus nerve might promote blood clotting nearly 20 years ago, after the nerve was found to modulate inflammation. The vagus nerve, which originates in the brain and branches out to other organs, controls the parasympathetic nervous system — the rest-and-digest counterpart to the “fight-or-flight” sympathetic nervous system.Sign up for the Live Science daily newsletter nowGet the world’s most fascinating discoveries delivered straight to your inbox.Contact me with news and offers from other Future brandsReceive email from us on behalf of our trusted partners or sponsorsBy submitting your information you agree to the Terms & Conditions and Privacy Policy and are aged 16 or over.Initial experiments in mice and pigs showed that stimulating the vagus could, indeed, reduce blood loss following a small cut. “We then spent the better part of a decade trying to figure out exactly how it works,” Huston said.Last year, Huston’s team showed that vagus nerve stimulation activates a type of immune cell, called T cells, in the spleen, the organ that helps filter germs and old cells out of blood. These T cells then activate platelets in the spleen; platelets are the cell fragments that set off blood clot formation.Upon re-entering circulation, the primed platelets are better able to respond to injury-related cues. In mice with hemophilia, a disorder in which blood can’t clot properly, nerve stimulation reduced bleeding, the team found.To test whether the same mechanism existed in humans, Huston’s team collaborated with the Dallas-based biomedical company Five Liters to recruit healthy volunteers. They used an approved device to zap the auricular branch of vagus nerve, which runs behind the ear, for 30 minutes in each person. They collected blood samples before and after the treatment.Following vagus nerve stimulation, the volunteers’ blood contained higher levels of markers of blood platelet activation.These results, published Nov. 13 on the National Library of Medicine website ClinicalTrials.gov, showed for the first time “that there is a neural tourniquet pathway in humans,” Huston said. “And it appears that we can activate this neural tourniquet pathway non-invasively.”While the past study results in animals are “very intriguing,” more work needs to be done to show vagus nerve stimulation can actually stop bleeding in humans, Peder Olofsson, a professor of bioelectronic medicine at the Karolinska Institute in Stockholm, Sweden, told Live Science.”Ultimately, measurements of bleeding times, bleeding volumes, and patient outcomes will be key” to demonstrating the clinical value of activating the vagus nerve through the skin, said Olofsson, who was not involved in the study.Huston agreed. “The next study will have to be in an actual clinical disease where the patients are bleeding one way or another,” he said.Another issue is showing that the stimulators can produce consistent results, Olofsson noted. “Non-invasive stimulators” — while much quicker and easier to use than implanted stimulators — “often show less consistent physiological effects.”Vagus nerve stimulation is already widely used in epilepsy and depression, so the risk of side effects is likely low, Huston added. If his findings can be replicated and extended in larger trials, surgeons might use a brief period of vagus nerve stimulation prior to planned surgeries.”We administer antibiotics, so you don’t get an infection during surgery. We administer pain medications pre-emptively, so the pain is less,” Huston said. “What is missing is any way to take a normal, healthy person who’s undergoing surgery to try and prevent bleeding ahead of time. That’s an enormous unmet need.”Ever wonder why some people build muscle more easily than others or why freckles come out in the sun? Send us your questions about how the human body works to [email protected] with the subject line “Health Desk Q,” and you may see your question answered on the website!

The SPOON Project Kicks-Off: Harnessing Citizen Science to Transform Food Systems

Current food systems are at the root of pressing environmental and social challenges. The SPOON project, funded by the European Union’s Horizon Europe programme, offers a transformative approach to tackling the interlinked challenges of European food systems by taking a citizen science approach.
Traditional top-down solutions have proven insufficient for addressing the complexities of modern food systems. SPOON reverses the approach by empowering citizens, alongside other food stakeholders, to act as co-creators of knowledge and solutions. At its core, SPOON employs a digital toolset that includes a multimedia questionnaire generator and a personal data wallet. These tools enable individuals to collect, analyse, and interpret data about their personal food consumption behaviours and local food environments. Citizens retain full control over their data while contributing to collective insights that guide the transition toward healthier and more sustainable food choices.
To achieve its vision, the project will:

Develop an analytical framework to better understand the factors influencing healthy and sustainable food consumption
Establish Citizen Science Labs (CSLs) and Behaviour Change Interventions (BCIs) to collect, visualise, and interpret data on food consumption behaviours and local food environments
Deploy the SPOON digital toolset to enable citizen-driven data collection and analysis
Create a GDPR-compliant data governance framework emphasising privacy, sharing, and interoperability
Develop guidelines and capacity-building programs to replicate and scale project insights
Draft policy recommendations to support data-driven decision-making and cross-sector collaboration

As project coordinator, the CSCP will oversee all activities and outcomes of the SPOON project, while specifically contributing in:

Investigating Europeans’ attitudes toward data sharing and participation in citizen science within the food sector.
Mapping stakeholders and operational settings across target regions (Germany, Greece, Italy, Belgium, Spain, and Slovenia).
Establishing Citizen Science Labs (CSLs) and Behaviour Change Interventions (BCIs) to examine food behaviours and promote sustainable diets.
Providing training and capacity-building through the Citizen Science Academy.
Supporting socio-economic and environmental assessments and evaluating the project’s impact, particularly within the CSLs.

The SPOON project will run from 2024 to 2028 and brings together 16 European partners.
For further information, please reach out to Arlind Xhelili.
Image source ideogram.ai